The 3D-printed products are indicated for posterior or transforaminal lumbar interbody fusion procedures in patients with degenerative disc disease.
The implants are the company’s first SPIRA products to enter the TLIF market, “the number one interbody market in the U.S. today,” Daniel Pontecorvo, Camber Spine co-founder and CEO, said in the release.
Mr. Pontecorvo said the company is looking to expand its reach in the TLIF market with a TLIF SPIRA cage product launch next year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
